According to the Latest Research Report,, the global market for Botanical Supplement and Drug should grow from US$ 19250 million in 2022 to US$ 30660 million by 2029, with a CAGR of 6.9% for the period of 2023-2029.
China Botanical Supplement and Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Botanical Supplement and Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Drugs segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Botanical Supplement and Drug include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Botanical dietary supplements, sometimes called herbals or herbal dietary supplements, are products made from plants, plant parts, or plant extracts. They are meant to be consumed and contain one or more ingredients meant to supplement the diet.
This report aims to provide a comprehensive study of the global market for Botanical Supplement and Drug.
Key Highlights of the Report
(1) Global Botanical Supplement and Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Botanical Supplement and Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Botanical Supplement and Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Botanical Supplement and Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Botanical Supplement and Drug segment by type and by application and regional segment by type and by application.
(6) Botanical Supplement and Drug industry supply chain, upstream, midstream and downstream analysis.
Key Regions Covered in This Report Are:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Drugs
Food and Beverages
Cosmetics
Market segment by application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
1 Market Overview
1.1 Product Overview and Scope of Botanical Supplement and Drug
1.2 Global Botanical Supplement and Drug Market Size and Forecast
1.3 China Botanical Supplement and Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Botanical Supplement and Drug Share in Global Market, 2018-2029
1.4.2 Botanical Supplement and Drug Market Size: China VS Global, 2018-2029
1.5 Botanical Supplement and Drug Market Dynamics
1.5.1 Botanical Supplement and Drug Market Drivers
1.5.2 Botanical Supplement and Drug Market Restraints
1.5.3 Botanical Supplement and Drug Industry Trends
1.5.4 Botanical Supplement and Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Botanical Supplement and Drug Revenue by Company (2018-2023)
2.2 Global Botanical Supplement and Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Botanical Supplement and Drug Concentration Ratio
2.4 Global Botanical Supplement and Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Botanical Supplement and Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Botanical Supplement and Drug Revenue by Company (2018-2023)
3.2 China Botanical Supplement and Drug Botanical Supplement and Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Botanical Supplement and Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Botanical Supplement and Drug Industry Chain
4.2 Botanical Supplement and Drug Upstream Analysis
4.3 Botanical Supplement and Drug Midstream Analysis
4.4 Botanical Supplement and Drug Downstream Analysis
5 Sights by Type
5.1 Botanical Supplement and Drug Classification
5.1.1 Drugs
5.1.2 Food and Beverages
5.1.3 Cosmetics
5.2 By Type, Global Botanical Supplement and Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Botanical Supplement and Drug Revenue, 2018-2029
6 Sights by Application
6.1 Botanical Supplement and Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other
6.2 By Application, Global Botanical Supplement and Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Botanical Supplement and Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Botanical Supplement and Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Botanical Supplement and Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Botanical Supplement and Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Botanical Supplement and Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Botanical Supplement and Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Botanical Supplement and Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Botanical Supplement and Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Botanical Supplement and Drug Market Size Market Share
7.6 South America
7.6.1 South America Botanical Supplement and Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Botanical Supplement and Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Botanical Supplement and Drug Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Botanical Supplement and Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Botanical Supplement and Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Botanical Supplement and Drug Market Size, 2018-2029
8.4.2 By Company, Europe Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Botanical Supplement and Drug Market Size, 2018-2029
8.5.2 By Company, China Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Botanical Supplement and Drug Market Size, 2018-2029
8.6.2 By Company, Japan Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Botanical Supplement and Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Botanical Supplement and Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Botanical Supplement and Drug Market Size, 2018-2029
8.9.2 By Company, India Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Botanical Supplement and Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Botanical Supplement and Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Buchang Pharmaceuticals
9.1.1 Buchang Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.1.2 Buchang Pharmaceuticals Company Profile and Main Business
9.1.3 Buchang Pharmaceuticals Botanical Supplement and Drug Models, Specifications and Application
9.1.4 Buchang Pharmaceuticals Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.1.5 Buchang Pharmaceuticals Recent Developments
9.2 China TCM
9.2.1 China TCM Company Information, Head Office, Market Area and Industry Position
9.2.2 China TCM Company Profile and Main Business
9.2.3 China TCM Botanical Supplement and Drug Models, Specifications and Application
9.2.4 China TCM Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.2.5 China TCM Recent Developments
9.3 Tsumura
9.3.1 Tsumura Company Information, Head Office, Market Area and Industry Position
9.3.2 Tsumura Company Profile and Main Business
9.3.3 Tsumura Botanical Supplement and Drug Models, Specifications and Application
9.3.4 Tsumura Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.3.5 Tsumura Recent Developments
9.4 Schwabe
9.4.1 Schwabe Company Information, Head Office, Market Area and Industry Position
9.4.2 Schwabe Company Profile and Main Business
9.4.3 Schwabe Botanical Supplement and Drug Models, Specifications and Application
9.4.4 Schwabe Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.4.5 Schwabe Recent Developments
9.5 Tong Ren Tang
9.5.1 Tong Ren Tang Company Information, Head Office, Market Area and Industry Position
9.5.2 Tong Ren Tang Company Profile and Main Business
9.5.3 Tong Ren Tang Botanical Supplement and Drug Models, Specifications and Application
9.5.4 Tong Ren Tang Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.5.5 Tong Ren Tang Recent Developments
9.6 Jumpcan Pharmaceutical
9.6.1 Jumpcan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.6.2 Jumpcan Pharmaceutical Company Profile and Main Business
9.6.3 Jumpcan Pharmaceutical Botanical Supplement and Drug Models, Specifications and Application
9.6.4 Jumpcan Pharmaceutical Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.6.5 Jumpcan Pharmaceutical Recent Developments
9.7 Guangzhou Baiyunshan Pharmaceutical
9.7.1 Guangzhou Baiyunshan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.7.2 Guangzhou Baiyunshan Pharmaceutical Company Profile and Main Business
9.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Supplement and Drug Models, Specifications and Application
9.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
9.8 Yunnan Baiyao
9.8.1 Yunnan Baiyao Company Information, Head Office, Market Area and Industry Position
9.8.2 Yunnan Baiyao Company Profile and Main Business
9.8.3 Yunnan Baiyao Botanical Supplement and Drug Models, Specifications and Application
9.8.4 Yunnan Baiyao Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.8.5 Yunnan Baiyao Recent Developments
9.9 Tasly Holding Group
9.9.1 Tasly Holding Group Company Information, Head Office, Market Area and Industry Position
9.9.2 Tasly Holding Group Company Profile and Main Business
9.9.3 Tasly Holding Group Botanical Supplement and Drug Models, Specifications and Application
9.9.4 Tasly Holding Group Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.9.5 Tasly Holding Group Recent Developments
9.10 Bionorica Se
9.10.1 Bionorica Se Company Information, Head Office, Market Area and Industry Position
9.10.2 Bionorica Se Company Profile and Main Business
9.10.3 Bionorica Se Botanical Supplement and Drug Models, Specifications and Application
9.10.4 Bionorica Se Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.10.5 Bionorica Se Recent Developments
9.11 Huarun 999
9.11.1 Huarun 999 Company Information, Head Office, Market Area and Industry Position
9.11.2 Huarun 999 Company Profile and Main Business
9.11.3 Huarun 999 Botanical Supplement and Drug Models, Specifications and Application
9.11.4 Huarun 999 Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.11.5 Huarun 999 Recent Developments
9.12 Taiji
9.12.1 Taiji Company Information, Head Office, Market Area and Industry Position
9.12.2 Taiji Company Profile and Main Business
9.12.3 Taiji Botanical Supplement and Drug Models, Specifications and Application
9.12.4 Taiji Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.12.5 Taiji Recent Developments
9.13 Weleda
9.13.1 Weleda Company Information, Head Office, Market Area and Industry Position
9.13.2 Weleda Company Profile and Main Business
9.13.3 Weleda Botanical Supplement and Drug Models, Specifications and Application
9.13.4 Weleda Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.13.5 Weleda Recent Developments
9.14 Kwangdong
9.14.1 Kwangdong Company Information, Head Office, Market Area and Industry Position
9.14.2 Kwangdong Company Profile and Main Business
9.14.3 Kwangdong Botanical Supplement and Drug Models, Specifications and Application
9.14.4 Kwangdong Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.14.5 Kwangdong Recent Developments
9.15 GW Pharmaceuticals
9.15.1 GW Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.15.2 GW Pharmaceuticals Company Profile and Main Business
9.15.3 GW Pharmaceuticals Botanical Supplement and Drug Models, Specifications and Application
9.15.4 GW Pharmaceuticals Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
9.15.5 GW Pharmaceuticals Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Botanical Supplement and Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Botanical Supplement and Drug Market Restraints
Table 3. Botanical Supplement and Drug Market Trends
Table 4. Botanical Supplement and Drug Industry Policy
Table 5. Global Botanical Supplement and Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Botanical Supplement and Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Botanical Supplement and Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Botanical Supplement and Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Botanical Supplement and Drug Manufacturers Product Type
Table 10. China Botanical Supplement and Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Botanical Supplement and Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Botanical Supplement and Drug Upstream (Raw Materials)
Table 13. Global Botanical Supplement and Drug Typical Customers
Table 14. Botanical Supplement and Drug Typical Distributors
Table 15. By Type, Global Botanical Supplement and Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Botanical Supplement and Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Botanical Supplement and Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Botanical Supplement and Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Botanical Supplement and Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Botanical Supplement and Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Botanical Supplement and Drug Revenue Market Share, 2018-2029
Table 22. Buchang Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 23. Buchang Pharmaceuticals Company Profile and Main Business
Table 24. Buchang Pharmaceuticals Botanical Supplement and Drug Models, Specifications and Application
Table 25. Buchang Pharmaceuticals Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 26. Buchang Pharmaceuticals Recent Developments
Table 27. China TCM Company Information, Head Office, Market Area and Industry Position
Table 28. China TCM Company Profile and Main Business
Table 29. China TCM Botanical Supplement and Drug Models, Specifications and Application
Table 30. China TCM Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 31. China TCM Recent Developments
Table 32. Tsumura Company Information, Head Office, Market Area and Industry Position
Table 33. Tsumura Company Profile and Main Business
Table 34. Tsumura Botanical Supplement and Drug Models, Specifications and Application
Table 35. Tsumura Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 36. Tsumura Recent Developments
Table 37. Schwabe Company Information, Head Office, Market Area and Industry Position
Table 38. Schwabe Company Profile and Main Business
Table 39. Schwabe Botanical Supplement and Drug Models, Specifications and Application
Table 40. Schwabe Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 41. Schwabe Recent Developments
Table 42. Tong Ren Tang Company Information, Head Office, Market Area and Industry Position
Table 43. Tong Ren Tang Company Profile and Main Business
Table 44. Tong Ren Tang Botanical Supplement and Drug Models, Specifications and Application
Table 45. Tong Ren Tang Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 46. Tong Ren Tang Recent Developments
Table 47. Jumpcan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 48. Jumpcan Pharmaceutical Company Profile and Main Business
Table 49. Jumpcan Pharmaceutical Botanical Supplement and Drug Models, Specifications and Application
Table 50. Jumpcan Pharmaceutical Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 51. Jumpcan Pharmaceutical Recent Developments
Table 52. Guangzhou Baiyunshan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 53. Guangzhou Baiyunshan Pharmaceutical Company Profile and Main Business
Table 54. Guangzhou Baiyunshan Pharmaceutical Botanical Supplement and Drug Models, Specifications and Application
Table 55. Guangzhou Baiyunshan Pharmaceutical Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 56. Guangzhou Baiyunshan Pharmaceutical Recent Developments
Table 57. Yunnan Baiyao Company Information, Head Office, Market Area and Industry Position
Table 58. Yunnan Baiyao Company Profile and Main Business
Table 59. Yunnan Baiyao Botanical Supplement and Drug Models, Specifications and Application
Table 60. Yunnan Baiyao Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 61. Yunnan Baiyao Recent Developments
Table 62. Tasly Holding Group Company Information, Head Office, Market Area and Industry Position
Table 63. Tasly Holding Group Company Profile and Main Business
Table 64. Tasly Holding Group Botanical Supplement and Drug Models, Specifications and Application
Table 65. Tasly Holding Group Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 66. Tasly Holding Group Recent Developments
Table 67. Bionorica Se Company Information, Head Office, Market Area and Industry Position
Table 68. Bionorica Se Company Profile and Main Business
Table 69. Bionorica Se Botanical Supplement and Drug Models, Specifications and Application
Table 70. Bionorica Se Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 71. Bionorica Se Recent Developments
Table 72. Huarun 999 Company Information, Head Office, Market Area and Industry Position
Table 73. Huarun 999 Company Profile and Main Business
Table 74. Huarun 999 Botanical Supplement and Drug Models, Specifications and Application
Table 75. Huarun 999 Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 76. Huarun 999 Recent Developments
Table 77. Taiji Company Information, Head Office, Market Area and Industry Position
Table 78. Taiji Company Profile and Main Business
Table 79. Taiji Botanical Supplement and Drug Models, Specifications and Application
Table 80. Taiji Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 81. Taiji Recent Developments
Table 82. Weleda Company Information, Head Office, Market Area and Industry Position
Table 83. Weleda Company Profile and Main Business
Table 84. Weleda Botanical Supplement and Drug Models, Specifications and Application
Table 85. Weleda Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 86. Weleda Recent Developments
Table 87. Kwangdong Company Information, Head Office, Market Area and Industry Position
Table 88. Kwangdong Company Profile and Main Business
Table 89. Kwangdong Botanical Supplement and Drug Models, Specifications and Application
Table 90. Kwangdong Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 91. Kwangdong Recent Developments
Table 92. GW Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 93. GW Pharmaceuticals Company Profile and Main Business
Table 94. GW Pharmaceuticals Botanical Supplement and Drug Models, Specifications and Application
Table 95. GW Pharmaceuticals Botanical Supplement and Drug Revenue and Gross Margin, 2018-2023
Table 96. GW Pharmaceuticals Recent Developments
List of Figure
Figure 1. Botanical Supplement and Drug Picture
Figure 2. Global Botanical Supplement and Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Botanical Supplement and Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Botanical Supplement and Drug Market Share of Global
Figure 5. Global Botanical Supplement and Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Botanical Supplement and Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Botanical Supplement and Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Botanical Supplement and Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Botanical Supplement and Drug Industry Chain
Figure 10. Drugs
Figure 11. Food and Beverages
Figure 12. Cosmetics
Figure 13. By Type, Global Botanical Supplement and Drug Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global Botanical Supplement and Drug Revenue Market Share, 2018-2029
Figure 15. Hospital
Figure 16. Retail Pharmacy
Figure 17. Other
Figure 18. By Application, Global Botanical Supplement and Drug Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Botanical Supplement and Drug Revenue Market Share, 2018-2029
Figure 20. By Region, Global Botanical Supplement and Drug Revenue Market Share, 2018-2029
Figure 21. North America Botanical Supplement and Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Botanical Supplement and Drug Revenue Market Share, 2018-2023
Figure 23. Europe Botanical Supplement and Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Botanical Supplement and Drug Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Botanical Supplement and Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Botanical Supplement and Drug Revenue Market Share, 2018-2023
Figure 27. South America Botanical Supplement and Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Botanical Supplement and Drug Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Botanical Supplement and Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Botanical Supplement and Drug Market Share, 2018-2023
Figure 32. By Type, U.S. Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 34. Europe Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Botanical Supplement and Drug Market Share, 2018-2023
Figure 36. By Type, Europe Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 38. China Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Botanical Supplement and Drug Market Share, 2018-2023
Figure 40. By Type, China Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 42. Japan Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Botanical Supplement and Drug Market Share, 2018-2023
Figure 44. By Type, Japan Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Botanical Supplement and Drug Market Share, 2018-2023
Figure 48. By Type, South Korea Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Botanical Supplement and Drug Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 54. India Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Botanical Supplement and Drug Market Share, 2018-2023
Figure 56. By Type, India Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Botanical Supplement and Drug Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Botanical Supplement and Drug Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Botanical Supplement and Drug Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|